ALDX - Aldeyra Therapeutics Stock Trading

Windtree Therapeutics ( OTCQB:WINT ): planning to study its KL4 surfactant to potentially mitigate pulmonary effects of severe COVID-19 infection. More news on: Windtree Therapeutics, Inc., Enzo Biochem, Inc., Aldeyra Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Re...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for potential anti-inflammatory and antiviral activity in the treatment of COVID-19 infection. ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...